Cerebrospinal Fluid Levels of Phosphorylated Neurofilament Heavy as a Diagnostic Marker of Canine Degenerative Myelopathy
Open Access
- 1 March 2017
- journal article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 31 (2) , 513-520
Abstract
No definitive, antemortem diagnostic test for canine degenerative myelopathy (DM) is available. Phosphorylated neurofilament heavy (pNF-H) is a promising biomarker for nervous system diseases. Cerebrospinal fluid (CSF) and serum pNF-H is a detectable biological marker for diagnosis of canine DM. Fifty-three DM-affected, 27 neurologically normal, 7 asymptomatic at-risk, and 12 DM mimic dogs. Archived CSF and serum pNF-H concentrations were determined by a commercially available ELISA. A receiver-operating characteristic (ROC) curve was generated with CSF values. Compared with old control dogs, median CSF pNF-H concentration was increased in all stages of DM; old dogs 5.1 ng/mL (interquartile range [IQR] 1.4–9.3) versus DM stage 1 23.9 ng/mL (IQR 20.8–29.6; P < .05) versus DM stage 2 36.8 ng/mL (IQR 22.9–51.2; P < .0001) versus DM stage 3 25.2 ng/mL (IQR 20.2–61.8; P < .001) versus DM stage 4 38.0 ng/mL (IQR 11.6–59.9; P < .01). Degenerative myelopathy stage 1 dogs had increased median CSF pNF-H concentrations compared with asymptomatic, at-risk dogs (3.4 ng/mL [IQR 1.5–10.9; P < .01]) and DM mimics (6.6 ng/mL [IQR 3.0–12.3; P < .01]). CSF pNF-H concentration >20.25 ng/mL was 80.4% sensitive (confidence interval [CI] 66.09–90.64%) and 93.6% specific (CI 78.58–99.21%) for DM. Area under the ROC curve was 0.9467 (CI 0.92–0.9974). No differences in serum pNF-H concentration were found between control and DM-affected dogs. pNF-H concentration in CSF is a sensitive biomarker for diagnosis of DM. Although there was high specificity for DM in this cohort, further study should focus on a larger cohort of DM mimics, particularly other central and peripheral axonopathies.Keywords
Funding Information
- AKC Canine Health Foundation (#2165)
- American Boxer Charitable Foundation
This publication has 38 references indexed in Scilit:
- The chaperone protein clusterin may serve as a cerebrospinal fluid biomarker for chronic spinal cord disorders in the dogCell Stress and Chaperones, 2013
- Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Degenerative Myelopathy in a Bernese Mountain Dog with a Novel SOD1 Missense MutationJournal of Veterinary Internal Medicine, 2011
- Degenerative Myelopathy in 18 Pembroke Welsh Corgi DogsVeterinary Pathology, 2009
- The Phosphorylated Axonal Form of the Neurofilament Subunit NF-H (pNF-H) as a Blood Biomarker of Traumatic Brain InjuryJournal of Neurotrauma, 2008
- Clinical Characterization of a Familial Degenerative Myelopathy in Pembroke Welsh Corgi DogsJournal of Veterinary Internal Medicine, 2007
- All roads lead to disconnection? – Traumatic axonal injury revisitedActa Neurochirurgica, 2005
- Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injuryBiochemical and Biophysical Research Communications, 2005
- The protein phosphatase inhibitor okadaic acid increases axonal neurofilaments and neurite caliber, and decreases axonal microtubules in NB2a/d1 CellsJournal of Neuroscience Research, 1993
- Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and miceThe Anatomical Record, 1970